Ivermectin: facts and science are in its favour - Dr Nathi Mdladla, Dr Pinky Dr Ngcakani and Professor Colleen Aldous

Loading player...
In July, BizNews founder Alec Hogg spoke to Professor Colleen Aldous - an Associate Professor and Clinical Researcher at the University of KwaZulu-Natal who has boldly spoken out in favour of Ivermectin. Aldous stated clearly that she does not believe that Ivermectin is a 'miracle drug', but that there is more than enough evidence pointing towards its effectiveness. In July, BizNews published an article written by Professor Aldous in which she argued that the placement of our trust in a small group of experts who advocate against ivermectin is being done at the potential cost of human life. With the fact-based evidence in respect of Ivermectin's efficacy in the treatment of Covid-19 reaching an insurmountable level - one has to ask what the reasons are for the vehement argument against its use by institutions like the World Health Organisation. In this interview, BizNews spoke to Dr Nathi Mdladla, Dr Pinky Dr Ngcakani and Professor Colleen Aldous about the use of Ivermectin in conjunction with other alternative treatment as well as vaccination in order to treat Covid-19. Learn more about your ad choices. Visit megaphone.fm/adchoices
10 Aug 2021 11AM English South Africa Investing · Business News

Other recent episodes

Magnus Heystek: Why SA’s middle class is quietly being crushed

South Africans are being told everything is fine. Magnus Heystek says it’s a dangerous illusion. In a wide-ranging conversation with Alec Hogg, the veteran investment strategist warns that falling GDP per capita, rising taxes, weak property returns and flawed retirement structures are steadily hollowing out the middle class. From Regulation…
9 Jan 6AM 41 min

South Africa’s business titans are gone – and David Shapiro explains why

From Brian Joffe to Raymond Ackerman, South Africa once produced business giants who shaped the economy. David Shapiro argues they have been replaced by spreadsheet managers, over-regulation and compliance paralysis, and explains what that loss means for growth, risk-taking and the country’s future.
8 Jan 6AM 54 min